LIXTE Biotechnology plans to invest 25% of its treasury in cryptocurrencies such as bitcoin
2025-08-13 11:58:59
The board of directors of biopharmaceutical company LIXTE Biotechnology Holdings has approved a strategic capital allocation plan to invest up to 25% of the corporate treasury in cryptocurrencies, including bitcoin and other digital assets. The specific transaction size and timing will be determined based on market conditions and strategic considerations.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
LIXTE Biotechnology计划将财库的25%投资比特币等加密货币Next article：
约25%的比特币存放在硬件冷钱包中，无法产生任何收益
